With subcutaneous liraglutide treatment, Chen et al
The pipeline of next-generation treatments is advancing rapidly: Novo Nordisks CagriSema, a fixed-dose combination of semaglutide and the amylin analogue cagrilintide, has an FDA decision expected in late 2026 and could further accelerate the market
Verchere, Torben Hansen, Fredrik Karpe, Jens J
Rejuvenize Peel The strongest SkinMedica treatment that improves overall skin condition from moderate to severe skin imperfections
After a month-long break, a conservative approach often involves restarting at a lower dosetypically the starting dose of 2.5 mg weekly or one step below the previous maintenance dosethen re-escalating according to the standard titration schedule
2 When will CVS begin offering Zepbound